Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MIRENA vs MIRVETUXIMAB SORAVTANSINE-GYNX: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MIRENA vs MIRVETUXIMAB SORAVTANSINE-GYNX: Safety Overview

Metric MIRENA MIRVETUXIMAB SORAVTANSINE-GYNX
Total FAERS Reports 3,769 1,086
Deaths Reported 8 91
Death Rate 0.2% 8.4%
Hospitalizations 597 120
Average Patient Age 31.0 yrs 64.3 yrs
% Female Patients N/A 99.7%
Marketing Status N/A Prescription